Loading
A phase 2 trial of nab-paclitaxel in pancreatic cancer, run by Loma Linda University, now recruiting.
Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer is a phase 2, interventional study registered as NCT03492671 by Loma Linda University, with a registry enrolment figure of 30 participants, started 2019-07-17 and due to reach its primary completion in 2026-09. Interventions recorded: Gemcitabine 1000 mg; nab-paclitaxel; Stereotactic Body Radiation Therapy. Conditions listed: Pancreas Adenocarcinoma; Resectable Pancreatic Cancer. Primary outcome: Curative Intent Resection (R0) rate. Pancreatic eligibility wording from the registry: "* Cytologic or histologic proof of adenocarcinoma of the pancreas". Sites: United States. No results are recorded here; the registry entry is the source.
Shares SBRT / SABR (stereotactic radiotherapy), Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares SBRT / SABR (stereotactic radiotherapy), Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, SBRT / SABR (stereotactic radiotherapy), Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag pancreatic-deep-dive.